Close Menu

Note: This story has been updated with additional information from the company's earnings call.

NEW YORK – Roche on Thursday reported a 6 percent increase in sales of its diagnostics division for full-year 2020, driven primarily by its COVID-19 testing portfolio.

Overall, Roche reported CHF 58.32 billion ($64.66 billion) in revenues for the year, down 5 percent from CHF 61.47 in 2019, but up 1 percent at constant exchange rates, the firm said.

The pharmaceuticals division had CHF 44.53 billion in 2020 revenues, down 8 percent from CHF 48.52 billion in 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.